Health-related technologies have evolved significantly in the modern world, offering people innovative tools to manage their ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Introduction to Digital Health and WellnessThe digital health and wellness industry is experiencing significant growth as healthcare increasingly incorporates technology to improve the quality, ...

Glucose monitoring has evolved beyond its traditional role in diabetes management, with an increasing number of people using ...

Daewoong Pharmaceutical launches thynC remote patient monitoring with insurance coverage Innovative remote monitoring system ...

Abbott Laboratories’ ABT growth in the fourth quarter of 2024 can be attributed to strong improvement in global Core ...

With a solid foundation for growth and a promising outlook, the global lancet market is on track to achieve its projected USD ...

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

Thus when Dr. Hon Pak, Samsung Senior Vice President and head of mobile digital health, divulged that work on blood glucose monitoring (on presumably a wearable) is going in a positive direction ...

The Omnitest plus blood glucose monitor consist of a sensor system for measuring blood glucose in capillary blood. The Omnitest® plus system provides a quick and easy way to measure the blood ...

What is a blood transfusion? A blood transfusion involves receiving donated blood or blood parts into your body through one of your blood vessels. A needle is put into a vein, often in the arm. The ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...